Announcement: New office hours

Starting March 6, 2017 Nationwide Medical Review will observe new office hours:

Monday through Friday:  8am – 7pm EST

Saturday:  9am – 12pm EST

Drug Overview

Important information regarding METHCATHINONE drug use.

Methcathinone is one of the more recent drugs of abuse in the United States and was placed into Schedule I of the CSA in 1993. Known on the streets as “Cat,” it is a structural analogue of methamphetamine and cathinone. Clandestinely manufactured, methcathinone is almost exclusively sold in the stable and highly water soluble hydrochloride salt form. It is most commonly snorted, although it can be taken orally by mixing it with a beverage or diluted in water and injected intravenously.

Methcathinone has an abuse potential equivalent to methamphetamine, and produces amphetamine-like activity including superabundant energy, hyperactivity, extended wakefulness and loss of appetite. Pleasant effects include a burst of energy, speeding of the mind, increased feelings of invincibility and euphoria. Unpleasant effects include anxiety, tremor, insomnia, weight loss, dehydration, sweating, stomach pains, pounding heart, nose bleeds and body aches. Toxic levels may produce convulsions, paranoia, and hallucinations. Like other CNS stimulants, binges are usually followed by a “crash” with periods of variable depression.

KHAT For centuries, khat, the fresh young leaves of the Catha edulis shrub, have been consumed where the plant is cultivated, primarily in East Africa and the Arabian peninsula. There, chewing khat predates the use of coffee and is used in a similar social context. Chewed in moderation, khat alleviates fatigue and reduces appetite. Compulsive use may result in manic behavior with grandiose delusions or in a paranoid type of illness, sometimes accompanied by hallucinations.

Khat has been brought into the United States and other countries for use by emigrants from the source countries. It contains a number of chemicals among which are two controlled substances, cathinone (Schedule I) and cathine (Schedule IV). As the leaves mature or dry, cathinone is converted to cathine, which significantly reduces its stimulatory properties.

[Abstracted from D.E.A. website q.v.]

Drug Effects